Search research articles
Contact Us
Filters
Showing results (1091-1100 of 1,281) with videos related to
Page
of 129
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 2015
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection
Ming-Sound Tsao, Sophie Marguet, Gwénaël Le Teuff, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 27, 2018
Nivolumab Plus Erlotinib in Patients With EGFR-Mutant Advanced NSCLC
Scott Gettinger, Matthew D Hellmann, Laura Q M Chow, et al.
Pharmacogenetics and Genomics
|
July 22, 2009
Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes
Penelope A Bradbury, Matthew H Kulke, Rebecca S Heist, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 26, 2017
Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC)
Catherine Labbé, Michael Cabanero, Grzegorz J Korpanty, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 20, 2022
Treatment patterns and outcomes in early-stage ALK-rearranged non-small cell lung cancer
Sabine Schmid, Miguel Garcia, Sierra Cheng, et al.
Current Oncology (Toronto, Ont.)
|
December 31, 2020
Longitudinal health utilities, symptoms and toxicities in patients with <i>ALK-</i>rearranged lung cancer treated with tyrosine kinase inhibitors: a prospective real-world assessment
B C Tse, B I Said, Z J Fan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2015
Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Giorgio Scagliotti, Joachim von Pawel, Silvia Novello, et al.
The Journal of Molecular Diagnostics : JMD
|
May 12, 2015
Analytical Performance of a 15-Gene Prognostic Assay for Early-Stage Non-Small-Cell Lung Carcinoma Using RNA-Stabilized Tissue
Shuguang Huang, Nicholas J Reitze, Amy L Ewing, et al.
Breast Cancer Research : BCR
|
October 30, 2019
Automated volumetric breast density measures: differential change between breasts in women with and without breast cancer
Kathleen R Brandt, Christopher G Scott, Diana L Miglioretti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2014
Second-hand smoke as a predictor of smoking cessation among lung cancer survivors
Lawson Eng, Jie Su, Xin Qiu, et al.
Page
of 129
Search research articles
Search
Showing results (1091-1100 of 1,281) with videos related to
Sort By:
Page
of 129
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 2015
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection
Ming-Sound Tsao, Sophie Marguet, Gwénaël Le Teuff, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 27, 2018
Nivolumab Plus Erlotinib in Patients With EGFR-Mutant Advanced NSCLC
Scott Gettinger, Matthew D Hellmann, Laura Q M Chow, et al.
Pharmacogenetics and Genomics
|
July 22, 2009
Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes
Penelope A Bradbury, Matthew H Kulke, Rebecca S Heist, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 26, 2017
Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC)
Catherine Labbé, Michael Cabanero, Grzegorz J Korpanty, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 20, 2022
Treatment patterns and outcomes in early-stage ALK-rearranged non-small cell lung cancer
Sabine Schmid, Miguel Garcia, Sierra Cheng, et al.
Current Oncology (Toronto, Ont.)
|
December 31, 2020
Longitudinal health utilities, symptoms and toxicities in patients with <i>ALK-</i>rearranged lung cancer treated with tyrosine kinase inhibitors: a prospective real-world assessment
B C Tse, B I Said, Z J Fan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2015
Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Giorgio Scagliotti, Joachim von Pawel, Silvia Novello, et al.
The Journal of Molecular Diagnostics : JMD
|
May 12, 2015
Analytical Performance of a 15-Gene Prognostic Assay for Early-Stage Non-Small-Cell Lung Carcinoma Using RNA-Stabilized Tissue
Shuguang Huang, Nicholas J Reitze, Amy L Ewing, et al.
Breast Cancer Research : BCR
|
October 30, 2019
Automated volumetric breast density measures: differential change between breasts in women with and without breast cancer
Kathleen R Brandt, Christopher G Scott, Diana L Miglioretti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2014
Second-hand smoke as a predictor of smoking cessation among lung cancer survivors
Lawson Eng, Jie Su, Xin Qiu, et al.
Page
of 129